Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ZYMEWORKS INC. (ZYME) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ZYMEWORKS INC. (ZYME), most recent 12 months reported: revenue $37.13M, net loss $149.99M, free cash flow -$120.54M. Latest balance sheet on file: liquid cash $270.7M. From SEC filings. Others in Pharmaceutical Preparations: INTEGRATED BIOPHARMA INC · LEXICON PHARMACEUTICALS, INC. · BGM Group Ltd · Cue Biopharma, Inc. · Zomedica Corp. · vTv Therapeutics Inc. · Foghorn Therapeutics Inc. · EARTH SCIENCE TECH, INC.

Stock screener

Watchlist